43 Result(s)

Partnership : Academics = , Industrials = , Financial investitors =

• • AUSTRIA
  • WIEN
  • WIEN
  • Molecular characterization of uncommon splice-mutations in neurofibromatosis type 1
  • Medizinische Universität Wien
  • Klinisches Institut für Medizinische und Chemische Labordiagnostik
  • More details
• • AUSTRIA
  • WIEN
  • WIEN
  • Role of the NF1 gene as a tumor suppressor gene in NF1-associated tumors and other NF1 symptoms
  • Medizinische Universität Wien
  • Klinisches Institut für Medizinische und Chemische Labordiagnostik
  • More details
• • BELGIUM
  • OOST-VLAANDEREN
  • GENT
  • Study of the genotype / phenotype correlation in genetic brain diseases
  • Ghent University Hospital - UZGent
  • Center for Medical Genetics
  • More details
• • BELGIUM
  • VLAAMS BRABANT
  • LEUVEN
  • Characterization of large NF1 gene deletions.
  • University Hospitals Leuven - Gasthuisberg
  • Clinical Genetics Unit
  • More details
• • BELGIUM
  • VLAAMS BRABANT
  • LEUVEN
  • The impact of NF1 microdeletions and tumor development in NF1.
  • University Hospitals Leuven - Gasthuisberg
  • Clinical Genetics Unit
  • More details
• • BELGIUM
  • VLAAMS BRABANT
  • LEUVEN
  • Identification and characterisation of new tumor suppressor genes involved in the formation of neurofibromas an MPNSTs in patients with neurofibromatosis type I.
  • University Hospitals Leuven - Gasthuisberg
  • Clinical Genetics Unit
  • More details
• • BELGIUM
  • VLAAMS BRABANT
  • LEUVEN
  • Molecular pathogenesis of tumors in neurofibromatosis type 1.
  • University Hospitals Leuven - Gasthuisberg
  • Clinical Genetics Unit
  • More details
• • FINLAND
  • Länsi-Suomen lääni
  • TURKU
  • Clinical research study on neurofibromatosis type 1 in Finland
  • Central Hospital University of Turku
  • Department of Cell Biology and Anatomy
  • More details
• • FRANCE
  • CENTRE
  • TOURS
  • Morpho-functional characterization of cerebral hamartomas in type 1 neurofibromatosis: study of the correlations with scholar training troubles
  • CHRU de Clocheville
  • Service de neuropédiatrie
  • More details
• • FRANCE
  • CENTRE
  • TOURS
  • Clinical research on type 1 neurofibromatosis
  • CHU Hôpital Trousseau
  • Service de dermatologie
  • More details
• • FRANCE
  • ILE DE FRANCE
  • CLICHY
  • Genotype-phenotype analysis: study of expressivity of type 1 and type 2 neurofibromatoses
  • Hôpital Beaujon
  • Service de neurochirurgie
  • More details
• • FRANCE
  • ILE DE FRANCE
  • CRETEIL
  • NF-France: patients at risk for evolutivity during Neurofibromatosis I study phenotypicgenotypic and proteomic comparising in a cohort
  • CHU Hôpital Henri Mondor
  • Centre d'Investigation Clinique
  • More details
• • FRANCE
  • ILE DE FRANCE
  • CRETEIL
  • NF-France: study of neurofibromatosis type 1 expressivity and genotype/phenotype correlation
  • CHU Hôpital Henri Mondor
  • Service de dermatologie
  • More details
• • FRANCE
  • ILE DE FRANCE
  • PARIS
  • Genetic diversity and phenotypic monotonicity of non-atheromatous arterial aneurysms
  • CHU Hôpital Xavier Bichat - Claude Bernard
  • Service de cardiologie
  • More details
• • FRANCE
  • ILE DE FRANCE
  • PARIS
  • Child neurofibromatosis: french study group on neurofibromatosis
  • Hopital Necker - Enfants Malades
  • Service de dermatologie
  • More details
• • FRANCE
  • ILE DE FRANCE
  • PARIS
  • Neurofibromatosis type 1: physiopathology of neurofibromes and their transformation into neursarcomes
  • Université Paris 5 - Faculté des sciences pharmaceutiques et biologiques
  • Génétique et Biothérapies des maladies dégénératives et prolifératives du système nerveux
  • More details
• • FRANCE
  • ILE DE FRANCE
  • PARIS
  • NF-FRANCE: modifier genes identification and role of normal and deleterious allelic variants of NF1 gene in the occurence and involvement of neurofibromatomes in the type 1 neurofibromatosis
  • Université Paris 5 - Faculté des sciences pharmaceutiques et biologiques
  • Génétique et Biothérapies des maladies dégénératives et prolifératives du système nerveux
  • More details
• • FRANCE
  • ILE DE FRANCE
  • VILLEJUIF
  • Tumor management in type 1 neurofibromatosis patients
  • Institut Gustave Roussy
  • Département de cancérologie de l'enfant et de l'adolescent
  • More details
• • FRANCE
  • ILE DE FRANCE
  • VILLEJUIF
  • Experimental therapy of neurological tumours (brain tumours and neuroblastoma)
  • Institut Gustave Roussy
  • Département de cancérologie de l'enfant et de l'adolescent
  • More details
• • FRANCE
  • PAYS DE LOIRE
  • NANTES
  • Evaluation of NF-1 children and adults learning disorders
  • CHU de Nantes - Hôtel Dieu
  • Clinique dermatologique
  • More details
• • FRANCE
  • RHONE-ALPES
  • LYON
  • Clinical and molecular study of the variation of the phenotypic expression in type1 neurofibromatosis
  • CHRU de Lyon - Hôpital Edouard Herriot
  • Service de génétique moléculaire et clinique
  • More details
• • GERMANY
  • Berlin
  • BERLIN
  • NF1 : FGF signaling in the genesis of multiple bone phenotypes in transgene (Nf1Prx1) mice
  • Max-Planck-Institut für molekulare Genetik
  • Research Group Mundlos
  • More details
• • GERMANY
  • Berlin
  • BERLIN
  • NF1 : Lovastatin treatment of transgenic (Nf1Prx1) mice
  • Max-Planck-Institut für molekulare Genetik
  • Research Group Mundlos
  • More details
• • GREECE
  • ATTIKI
  • VARI
  • 
  • The receptor tyrosine kinase ALK as a novel target for the treatment of neurofibromatosis 1
  • Alexander Fleming - Biomedical Sciences Research Center
  • Institute of Molecular and Genetic Biology
  • More details
• • ITALY
  • CAMPANIA
  • SALERNO
  • Neurofibromatosis 1 (NF1): refine FISH characterization of microdeletion syndromes, definition of genotype-phenotyoe correlation
  • Centro Zigote S.r.L.
  • More details
• • ITALY
  • EMILIA ROMAGNA
  • BOLOGNA
  • Mesenchymal stem cells for the treatment of tibial congenital pseudarthrosis associated with type 1 Neurofibromatosis
  • Istituto Ortopedico Rizzoli
  • Laboratorio di Fisopatologia degli Impianti Ortopedici
  • More details
• • ITALY
  • LAZIO
  • ROMA
  • Mechanisms of variable expressivity in the Neurofibromatosis type1
  • Istituto CSS-Mendel
  • Laboratorio di Biologia Molecolare e Citogenetica
  • More details
• • ITALY
  • LIGURIA
  • GENOVA
  • Relationship between learning disability, with or withourt cerebral magnetic resonance T2 hyperintensities, and NF1 gene mutations
  • Istituto G. Gaslini - Ospedale Pediatrico IRCCS
  • Dipartimento di Scienze Pediatriche
  • More details
• • ITALY
  • LOMBARDIA
  • MILANO
  • Type 1 Neurofibromatosis: advanced diagnosis and characterization of malignant neurofibromas
  • Fondazione IRCCS Istituto Nazionale Neurologico "C. Besta"
  • Neuro-Oncologia Molecolare
  • More details
• • ITALY
  • PUGLIA
  • SAN GIOVANNI ROTONDO
  • Signature of the response of aggressive and metastatic tumours
  • IRCCS Ospedale Casa Sollievo della Sofferenza
  • Servizio di Patologia dell'Invecchiamento ed Oncologia
  • More details
• • ITALY
  • PUGLIA
  • SAN GIOVANNI ROTONDO
  • Signature of the response of aggressive and metastatic tumours
  • IRCCS Ospedale Casa Sollievo della Sofferenza
  • U.O. di Oncologia
  • More details
• • SPAIN
  • Cataluña
  • L'HOSPITALET DE LLOBREGAT
  • Study of Schwann cells forming neurofibromas. Description of genic expression profile in these cells and function determination of the neurofibromine in this tumoral type.
  • Instituto de Investigación Biomédica de Bellvitge (IDIBELL)
  • More details
• • SPAIN
  • Cataluña
  • L'HOSPITALET DE LLOBREGAT
  • Genetic study of the variability of the expression in Neurofibromatosis type I (NF1). Search of NF1 modifier genes.
  • Instituto de Investigación Biomédica de Bellvitge (IDIBELL)
  • More details
• • SPAIN
  • Cataluña
  • L'HOSPITALET DE LLOBREGAT
  • NF1 and NF2 mutations and neurologic tumors and familial neurofibromatosis
  • Instituto de Investigación Biomédica de Bellvitge (IDIBELL)
  • More details
• • SPAIN
  • Cataluña
  • L'HOSPITALET DE LLOBREGAT
  • Identification of mutational molecular mechanisms in Neurofibromatosis type 1
  • Instituto de Investigación Biomédica de Bellvitge (IDIBELL)
  • More details
• • SPAIN
  • Cataluña
  • L'HOSPITALET DE LLOBREGAT
  • Molecular and genetic analysis of Neurofibromatosis type I
  • Instituto de Investigación Biomédica de Bellvitge (IDIBELL)
  • More details
• • SPAIN
  • Cataluña
  • L'HOSPITALET DE LLOBREGAT
  • Therapeutic targets for neurofibromas: identification by cross-species gene expression analysis.
  • Instituto de Investigación Biomédica de Bellvitge (IDIBELL)
  • More details
• • SPAIN
  • Cataluña
  • L'HOSPITALET DE LLOBREGAT
  • DNA repair genes role as modifiers on the neurofibrome number in Neurofibromatosis 1 patients
  • Instituto de Investigación Biomédica de Bellvitge (IDIBELL)
  • More details
• • SPAIN
  • Cataluña
  • L'HOSPITALET DE LLOBREGAT
  • Therapeutic approaches to the neurofibromatosis Type 1 (NF1). Design of a model for the study of the splicing modulation by different compounds
  • Instituto de Investigación Biomédica de Bellvitge (IDIBELL)
  • More details
• • SPAIN
  • Madrid
  • MADRID
  • Genomic, Epigenetic and Transcriptional Study of Tumours in Polymalformative Genetic Syndromes
  • Hospital Infantil Universitario la Paz
  • Unidad de Hemato-Oncologia y trasplante de Médula Ósea Pediátrica
  • More details
• • SPAIN
  • Madrid
  • MADRID
  • Genetic basis of phenotypic variability of Neurofibromatosis type 1: regulation of mRNA processing and modifier genes for complex phenotypes
  • Hospital Universitario Ramón y Cajal
  • Unidad de Genética Molecular
  • More details
• • SPAIN
  • Madrid
  • MADRID
  • Genetic studies of Neurofibromatosis: Designing a protocol for the molecular genetic diagnosis of Neurofibromatosis type 2 and analysis of phenotypic variability of Neurofibromatosis type 1
  • Hospital Universitario Ramón y Cajal
  • Unidad de Genética Molecular
  • More details
• • SPAIN
  • Madrid
  • MADRID
  • Genomic, Epigenetic and Transcriptional Study of Tumours in Polymalformative Genetic Syndromes
  • Instituto de Genética Médica y Molecular (INGEMM). Hospital Universitario La Paz
  • Sección de Genómica Estructural y Funcional
  • More details